¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"ȯ"¿¡ ´ëÇÑ KI ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
susceptibility
°¨¼ö¼º, ÀÌȯ¼º, ÀÚÈÀ²
testicle
°íȯ
testicular
°íȯÀÇ
testicular insufficiency
°íȯ±â´ÉºÎÀü(Áõ)
testis
°íȯ
thromboembolic disease
Ç÷Àü»öÀü¼ºÁúȯ
transducer
º¯È¯±â, º¯È¯ÀåÄ¡, Æ®·£½ºµà¼, ŽÃËÀÚ
two dimensional Fourier transform
ÀÌÂ÷¿øÇ»¸®¾îº¯È¯
underlying disease
¿øÁúȯ, ±âÃÊÁúȯ
undescended testes
Á¤·ù°íȯ, ºÒ°Çϰíȯ
urinary diversion
¿ä·ÎÀüȯ¼ú
valve replacement
ÀΰøÆÇġȯ
valvular heart disease
ÆÇ¸·¼º½ÉÁúȯ
ventilation
Åëdz, ȯ±â
vicious circle
¾Ç¼øÈ¯
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½